Chen, X.; Laurent, A.; Liao, Z.; Jaccoud, S.; Abdel-Sayed, P.; Flahaut, M.; Scaletta, C.; Raffoul, W.; Applegate, L.A.; Hirt-Burri, N.
Cutaneous Cell Therapy Manufacturing Timeframe Rationalization: Allogeneic Off-the-Freezer Fibroblasts for Dermo-Epidermal Combined Preparations (DE-FE002-SK2) in Burn Care. Pharmaceutics 2023, 15, 2334.
https://doi.org/10.3390/pharmaceutics15092334
AMA Style
Chen X, Laurent A, Liao Z, Jaccoud S, Abdel-Sayed P, Flahaut M, Scaletta C, Raffoul W, Applegate LA, Hirt-Burri N.
Cutaneous Cell Therapy Manufacturing Timeframe Rationalization: Allogeneic Off-the-Freezer Fibroblasts for Dermo-Epidermal Combined Preparations (DE-FE002-SK2) in Burn Care. Pharmaceutics. 2023; 15(9):2334.
https://doi.org/10.3390/pharmaceutics15092334
Chicago/Turabian Style
Chen, Xi, Alexis Laurent, Zhifeng Liao, Sandra Jaccoud, Philippe Abdel-Sayed, Marjorie Flahaut, Corinne Scaletta, Wassim Raffoul, Lee Ann Applegate, and Nathalie Hirt-Burri.
2023. "Cutaneous Cell Therapy Manufacturing Timeframe Rationalization: Allogeneic Off-the-Freezer Fibroblasts for Dermo-Epidermal Combined Preparations (DE-FE002-SK2) in Burn Care" Pharmaceutics 15, no. 9: 2334.
https://doi.org/10.3390/pharmaceutics15092334
APA Style
Chen, X., Laurent, A., Liao, Z., Jaccoud, S., Abdel-Sayed, P., Flahaut, M., Scaletta, C., Raffoul, W., Applegate, L. A., & Hirt-Burri, N.
(2023). Cutaneous Cell Therapy Manufacturing Timeframe Rationalization: Allogeneic Off-the-Freezer Fibroblasts for Dermo-Epidermal Combined Preparations (DE-FE002-SK2) in Burn Care. Pharmaceutics, 15(9), 2334.
https://doi.org/10.3390/pharmaceutics15092334
